Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

HIV Infection

Free Subscription 10.03.2025 1 Antimicrob Agents Chemother 3 Clin Infect Dis 3 HIV Med 4 J Acquir Immune Defic Syndr 2 J Clin Invest 5 J Infect Dis 1 J Med Virol 2 J Virol 1 JAMA 1 Pediatr Rev 4 PLoS One 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. MATTHEWS RP, Patel M, Liu W, Liu Y, et al
   Pharmacokinetics of islatravir in participants with moderate hepatic impairment.
   Antimicrob Agents Chemother. 2025 Mar 5:e0155324. doi: 10.1128/aac.01553.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. DE MIGUEL R, de Lagarde Sebastian M, Blanco Arevalo JL, Pinto-Martinez A, et al
   Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons with Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicentre, Phase IIA Clinical Trial.
   Clin Infect Dis. 2025 Mar 7:ciaf100. doi: 10.1093.
   PubMed         Abstract available
   
   
3. SOGE OO, Thibault CS, Cannon CA, McLaughlin SE, et al
   Potential Impact of Doxycycline Post-Exposure Prophylaxis on Tetracycline Resistance in Neisseria gonorrhoeae and Colonization with Tetracycline-Resistant Staphylococcus aureus and Group A Streptococcus.
   Clin Infect Dis. 2025 Feb 28:ciaf089. doi: 10.1093.
   PubMed         Abstract available
   
   
4. BURGOS J, Curran A, Garcia J, Campany D, et al
   Effectiveness of electrocautery, topical cidofovir and topical sinecatechins for the Treatment of Anal High-grade Squamous Intraepithelial Lesions in Persons with HIV: an open-label, randomized controlled trial.
   Clin Infect Dis. 2025 Feb 27:ciaf086. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   HIV Med

5. CHAWLA S, Kaida A, Brouillette MJ, Kleiner B, et al
   Impact of mental health service use on the HIV care cascade among women.
   HIV Med. 2025 Mar 4. doi: 10.1111/hiv.70008.
   PubMed         Abstract available
   
   
6. SURIYARACHCHI DDC, Katuwavila NP
   Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment.
   HIV Med. 2025 Mar 4. doi: 10.1111/hiv.13770.
   PubMed         Abstract available
   
   
7. HE X, Zheng W, Wang X, Jiang Y, et al
   Trend of HIV/AIDS disease burden in China from 1990 to 2021: An age-period-cohort model analysis.
   HIV Med. 2025 Mar 4. doi: 10.1111/hiv.70009.
   PubMed         Abstract available
   
   

   
   J Acquir Immune Defic Syndr

8. DASGUPTA S, Tie Y, Buchacz K, Koenig LJ, et al
   A novel method for assessing poor quality of life among people with HIV.
   J Acquir Immune Defic Syndr. 2025 Mar 5. doi: 10.1097/QAI.0000000000003644.
   PubMed         Abstract available
   
   
9. CHAILLON A, Gaitan NC, Taylor LE, Wu K, et al
   Predictors of Acute HCV Incidence in People with HIV: Insights from a Long-term Cohort Study.
   J Acquir Immune Defic Syndr. 2025 Mar 6. doi: 10.1097/QAI.0000000000003660.
   PubMed         Abstract available
   
   
10. PHILPOTT DC, Curran KG, Russell OO, McClung RP, et al
    HIV Clusters Reported by State and Local Health Departments in the United States, 2020-2022.
    J Acquir Immune Defic Syndr. 2025 Mar 6. doi: 10.1097/QAI.0000000000003658.
    PubMed         Abstract available
    
    
11. ZHAO Y, Holtman M, Mudaly V, van Zyl G, et al
    Resistance to Dolutegravir in Treatment-experienced Patients in South Africa: A Retrospective Cohort Study.
    J Acquir Immune Defic Syndr. 2025 Mar 3. doi: 10.1097/QAI.0000000000003657.
    PubMed         Abstract available
    
    

    
    J Clin Invest

12. KATUSIIME MG, Neer V, Guo S, Patro SC, et al
    Divergent populations of HIV-infected naive and memory CD4+ T-cell clones in children on antiretroviral therapy.
    J Clin Invest. 2025 Mar 6:e188533. doi: 10.1172/JCI188533.
    PubMed         Abstract available
    
    
13. RAMEZANI-RAD P, Marina-Zarate E, Maiorino L, Myers A, et al
    The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in non-human primates.
    J Clin Invest. 2025 Mar 4:e185292. doi: 10.1172/JCI185292.
    PubMed         Abstract available
    
    

    
    J Infect Dis

14. SHAIKH MW, Singh S, Giron LB, Zhang L, et al
    Compromised Intestinal Barrier Resilience to Disruption in People with HIV.
    J Infect Dis. 2025 Mar 6:jiaf119. doi: 10.1093.
    PubMed         Abstract available
    
    
15. MASIA M, Fernandez-Gonzalez M, Ledesma C, Losada-Echeberria M, et al
    Impact of switching to long-acting injectable cabotegravir plus rilpivirine on rectal HIV-1 RNA shedding and implications for transmission risk.
    J Infect Dis. 2025 Mar 5:jiaf117. doi: 10.1093.
    PubMed         Abstract available
    
    
16. CHESSON HW, Markowitz LE
    Strong Herd Effects of Human Papillomavirus Vaccination.
    J Infect Dis. 2025 Mar 5:jiaf121. doi: 10.1093.
    PubMed        
    
    
17. VAN GERWEN OT, Aaron KJ, Kay ES, Siwakoti K, et al
    The Impact of Testosterone Therapy on the Vaginal Microbiota of Transgender Men and Non-Binary People: A Prospective Study.
    J Infect Dis. 2025 Mar 3:jiaf114. doi: 10.1093.
    PubMed         Abstract available
    
    
18. DE GREEF J, Yombi JC, Vincent A, Vandercam B, et al
    Dolutegravir and Risk of Neuropsychiatric Adverse Events: a Pharmacogenetic Study.
    J Infect Dis. 2025 Feb 26:jiaf098. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

19. JIN Q, Zhou M, Sun M, Ning B, et al
    Global Temporal Trends in Mother-to-Child Transmission Disease Incidence Among Women of Child-Bearing Age: An Analysis of Global Burden of Disease Study 2021 Data.
    J Med Virol. 2025;97:e70283.
    PubMed         Abstract available
    
    

    
    J Virol

20. GC K, Lesko S, Emery A, Burnett C, et al
    HIV-1 single-transcription start-site mutants display complementary replication functions that are restored by reversion.
    J Virol. 2025 Mar 4:e0213924. doi: 10.1128/jvi.02139.
    PubMed         Abstract available
    
    
21. JANEVSKA M, Witkowski W, Vermeire J, Borowicz M, et al
    Impairment of endocytosis-related factors FNBP1L, ARHGAP24, and ATP6V1B1 increases HIV-1 entry into dendritic cells.
    J Virol. 2025 Mar 3:e0206624. doi: 10.1128/jvi.02066.
    PubMed         Abstract available
    
    

    
    JAMA

22. SPINELLI MA, Heise MJ, Gistand N, Cox C, et al
    HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People With and Without Initial Viremia.
    JAMA. 2025 Mar 6. doi: 10.1001/jama.2025.0109.
    PubMed        
    
    

    
    Pediatr Rev

23. ALVAREZ AM, Rathore MH
    Update in the Diagnosis and Treatment of Tuberculosis in Children.
    Pediatr Rev. 2025;46:148-158.
    PubMed        
    
    

    
    PLoS One

24. GWASUPIKA J, Hamer DH, Daka V, Chikwanda E, et al
    Antibiotic prescription patterns and associated symptoms in children living with HIV at Arthur Davison Children's Hospital in Ndola, Zambia.
    PLoS One. 2025;20:e0316735.
    PubMed         Abstract available
    
    
25. HANUM N, Cambiano V, Sewell J, Rodger AJ, et al
    Transitions in sexual behaviour among gay, bisexual, and other men who have sex with men in England: Data from a prospective study.
    PLoS One. 2025;20:e0308238.
    PubMed         Abstract available
    
    
26. GIRMAY G, Alemu H, Assefa M, Birhane N, et al
    Comparative evaluation of plasma and serum HIV-1 viral load measurements among HIV positive individuals, Northwest Ethiopia: Analytical cross-sectional study.
    PLoS One. 2025;20:e0315717.
    PubMed         Abstract available
    
    
27. CHAYAMA KL, Ng C, Brohman I, Mansoor M, et al
    Acceptability of long-acting antiretroviral therapy among people living with HIV who use drugs in Vancouver, Canada: A qualitative study.
    PLoS One. 2025;20:e0319010.
    PubMed         Abstract available
    
    

    
    Vaccine

28. ONYANDO BO, Nyawanda BO, Onguru D, Haidara FC, et al
    Factors associated with mortality among patients aged 12 years and above requiring hospitalization for severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023.
    Vaccine. 2025 Mar 1:126910. doi: 10.1016/j.vaccine.2025.126910.
    PubMed         Abstract available
    
    

    
    Virology

29. BENLARBI M, Kenfack DD, Dionne K, Cote-Chenette M, et al
    Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.
    Virology. 2025;605:110467.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.